Literature DB >> 20423606

The role of neuroinflammation on the pathogenesis of Parkinson's disease.

Young Cheul Chung1, Hyuk Wan Ko, Eugene Bok, Eun Soo Park, Sue Hee Huh, Jin Han Nam, Byung Kwan Jin.   

Abstract

Parkinson's Disease (PD) is a common neurodegenerative disease characterized by the progressive degeneration of nigrostriatal dopaminergic (DA) neurons. Although the causative factors of PD remain elusive, many studies on PD animal models or humans suggest that glial activation along with neuroinflammatory processes contribute to the initiation or progression of PD. Additionally, several groups have proposed that dysfunction of the blood-brain barrier (BBB) combined with infiltration of peripheral immune cells play important roles in the degeneration of DA neurons. However, these neuroinflammatory events have only been investigated separately, and the issue of whether these phenomena are neuroprotective or neurotoxic remains controversial. We here review the current knowledge regarding the functions of these neuroinflammatory processes in the brain. Finally, we describe therapeutic strategies for the regulation of neuroinflammation with the goal of improving the symptoms of PD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20423606     DOI: 10.5483/bmbrep.2010.43.4.225

Source DB:  PubMed          Journal:  BMB Rep        ISSN: 1976-6696            Impact factor:   4.778


  59 in total

Review 1.  Neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier.

Authors:  Michelle A Erickson; Kenji Dohi; William A Banks
Journal:  Neuroimmunomodulation       Date:  2012-01-11       Impact factor: 2.492

2.  An angiogenic inhibitor, cyclic RGDfV, attenuates MPTP-induced dopamine neuron toxicity.

Authors:  Aditiben Patel; Giuseppe V Toia; Kalea Colletta; Brinda Desai Bradaric; Paul M Carvey; Bill Hendey
Journal:  Exp Neurol       Date:  2011-06-15       Impact factor: 5.330

3.  Markers of inflammation in prevalent and incident Parkinson's disease in the Cardiovascular Health Study.

Authors:  Thanh G N Ton; Samay Jain; Mary L Biggs; Evan L Thacker; Elsa S Strotmeyer; Robert Boudreau; Anne B Newman; W T Longstreth; Harvey Checkoway
Journal:  Parkinsonism Relat Disord       Date:  2011-11-26       Impact factor: 4.891

4.  Evidence for angiogenesis in Parkinson's disease, incidental Lewy body disease, and progressive supranuclear palsy.

Authors:  Brinda Desai Bradaric; Aditiben Patel; Julie A Schneider; Paul M Carvey; Bill Hendey
Journal:  J Neural Transm (Vienna)       Date:  2011-07-12       Impact factor: 3.575

Review 5.  Kynurenines in Parkinson's disease: therapeutic perspectives.

Authors:  Dénes Zádori; Péter Klivényi; József Toldi; Ferenc Fülöp; László Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2011-08-20       Impact factor: 3.575

Review 6.  TREK-king the blood-brain-barrier.

Authors:  Stefan Bittner; Tobias Ruck; Juncal Fernández-Orth; Sven G Meuth
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-21       Impact factor: 4.147

Review 7.  Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration?

Authors:  Fábio G Teixeira; Miguel M Carvalho; Nuno Sousa; António J Salgado
Journal:  Cell Mol Life Sci       Date:  2013-03-01       Impact factor: 9.261

Review 8.  Mechanisms of islet amyloidosis toxicity in type 2 diabetes.

Authors:  Andisheh Abedini; Ann Marie Schmidt
Journal:  FEBS Lett       Date:  2013-01-18       Impact factor: 4.124

9.  Inflammatory cells and cytokines in the olfactory bulb of a rat model of neuroinflammation; insights into neurodegeneration?

Authors:  Marie-Francoise Doursout; Michael S Schurdell; Lauren M Young; Uzondu Osuagwu; Diana M Hook; Brian J Poindexter; Mya C Schiess; Diane L M Bick; Roger J Bick
Journal:  J Interferon Cytokine Res       Date:  2013-04-19       Impact factor: 2.607

10.  Evaluation of nigrostriatal neurodegeneration and neuroinflammation following repeated intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in mice, an experimental model of Parkinson's disease.

Authors:  Fabrine S M Tristão; Majid Amar; Ines Latrous; Elaine A Del-Bel; Rui D Prediger; Rita Raisman-Vozari
Journal:  Neurotox Res       Date:  2013-05-21       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.